Stock Updates

A look at a High Market Cap Stock: Fresenius Medical Care AG & Co. KGAA, FMS

Fresenius Medical Care AG & Co. KGAA, FMS is in the exchange NYSE and its industry is Specialized Health Services in the sector of Healthcare. Based in Germany, Fresenius Medical Care AG & Co. KGAA, FMS  has a market cap of 24187.1. Since its IPO date on the 9/17/1996, Fresenius Medical Care AG & Co. KGAA, FMS performance year to date is -4.84%. Today Fresenius Medical Care AG & Co. KGAA, FMS has gained -0.79%, with a current price of 39.1.

Ownership of the company is 35.70% for insider ownership while institutional ownership is 2.50%. The management of the company have seen the company have a payout ratio of 20.80%. Return of assets are at 4.50%, with return on investment at 9.10%.

In terms of debt levels and profit levels, Fresenius Medical Care AG & Co. KGAA, FMS is seeing a long-term debt/equity of 0.68. While Total debt/equity is 0.84. With a profit margin of 6.70%, this is combined with a gross margin of 32.20%, and operating margin of 14.30%. Fresenius Medical Care AG & Co. KGAA ability to meet debt levels, with a current ratio of 1.4, while the quick ratio is 1.1.

For the last year Fresenius Medical Care AG & Co. KGAA, FMS has seen a EPS growth of -2.00%. A performance for the year of -3.37%. The 52-week high is -17.72%, and the 52-week low is 2.76%. The average volume for Fresenius Medical Care AG & Co. KGAA, FMS is 46166.

With a target price of 46, can Fresenius Medical Care AG & Co. KGAA, FMS reach this target? Looking at the value indicators of Fresenius Medical Care AG & Co. KGAA, FMS. Fresenius Medical Care AG & Co. KGAA has a P/E of 20.55 and a forward P/E of 17.77. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.39. Fresenius Medical Care AG & Co. KGAA also has a P/S and a P/B of 1.38 and 2.28 respectively. For P/cash, Fresenius Medical Care AG & Co. KGAA has a value of 38.4, while it is 95.49 for P/free cash flow.

At the current price of 39.1, Fresenius Medical Care AG & Co. KGAA has a dividend yield of 1.15%. We see a return on equity of 11.50%.

Looking more long-term Fresenius Medical Care AG & Co. KGAA, is projected to get an EPS growth for the next five years of 8.60%. In the short-term an EPS growth of 9.64% in the next year is forecasted. This is after a EPS growth of -2.00% for this year and for the last five years a 15.90% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment